Recruiting NA INTERVENTIONAL 1-arm NCT05216900

Breast Reconstruction and Neoadjuvant Radiotherapy (BRENAR)

Breast Reconstruction and Neoadjuvant Therapy, a Changing Algorithm

Sponsor: Alexander Monro Hospital, Bilthoven

Updated 4 times since 2022 Last updated: Jun 18, 2024 Started: Apr 1, 2023 Primary completion: Dec 1, 2025 Completion: Dec 4, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05216900, this NA trial focuses on Breast Cancer and remains actively recruiting participants. Sponsored by Alexander Monro Hospital, Bilthoven, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2022 — Jun 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexander Monro Hospital, Bilthoven
Amsterdam UMC
Cancer Center Amsterdam grant for innovative research
UMC Utrecht

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bilthoven, Netherlands